- NEGATIVE
Annual Revenue Valencia Nutrition Mar-2026 Annual Revenue is Rs 7 Cr which is growth of -18.0% YoY.
- NEGATIVE
Annual Net Profit Valencia Nutrition Mar-2026 Annual Net Profit is Rs 1 Cr which is growth of -3.4% YoY.
BSE: 542910
Valencia Nutrition Live Share Price Today, Share Analysis and Chart
aboutValencia Nutrition Ltd. (now known as Valencia India Limited) is a specialist nutraceutical company focused on the development and marketing of functional beverages and clinical nutrition products. The company primarily targets the health-conscio... Read More
59.401.40(2.41%)
3,000
BSE Volume
BSE 11 Nov, 2026 3:31 PM (IST)
Valencia Nutrition Stock Price Analysis
Day Price Range2.4% 1 Day return | 59.4 (LTP) 59.359.5 LowHigh |
|---|---|
Week Price Range1.5% 1 Week return | 59.4 (LTP) 57.859.5 LowHigh |
Month Price Range-7.2% 1 Month return | 59.4 (LTP) 44.563.9 LowHigh |
52 Week Price Range-28.7% 1 Year return | 59.4 (LTP) 40.180 LowHigh |
Competitors/Peers
Revenue Mix
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Valencia Nutrition annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-17.6%
2Y CAGR
110%
3Y CAGR
71%
5Y CAGR
49.6%
7Y CAGR
25.8%
Total Revenue Annual is falling faster than historical averages.
Net Profit Ann.
1Y CHG
-9.1%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-24.7%
2Y CAGR
39%
3Y CAGR
29%
5Y CAGR
8.3%
7Y CAGR
7.1%
Operating Expenses Annual Cr is falling faster than historical averages.
Valencia Nutrition Technical Analysis
Valencia Nutrition EMA & SMA
Bullish+4
6 bullish, 2 bearish
Bullish6
Bearish2
| 5 Day | 58.5 |
|---|---|
| 10 Day | 58.6 |
| 12 Day | 58.6 |
| 20 Day | 58.4 |
| 26 Day | 58.2 |
|---|---|
| 50 Day | 58.6 |
| 100 Day | 60.3 |
| 200 Day | 59.5 |
Valencia Nutrition Delivery And Volume
Daily Avg. Delivery Volume %
11 Nov, 2026100.0%
Week100.0%
Month-
Valencia Nutrition Active Candlesticks
Short Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Valencia Nutrition Resistance and Support
59.40
Pivot
| First Resistance | 59.5 |
|---|---|
| Second Resistance | 59.6 |
| Third Resistance | 59.7 |
| First Support | 59.3 |
|---|---|
| Second Support | 59.2 |
| Third Support | 59.1 |
| Day RSI | 51.8 |
|---|---|
| Day MACD | 0.3 |
| Day MFI | 41.1 |
| Day MACD Signal Line | 0.6 |
Valencia Nutrition Beta
| 1 Month | -2.4 |
|---|---|
| 1 Year | -0.3 |
| 3 Month | -0.2 |
|---|---|
| 3 Year | - |
Valencia Nutrition Price Change Analysis
↓-7.2%
Over 1 Month
LowHigh
44.563.9
↑37.8%
Over 3 Months
LowHigh
44.568.9
↓-15.1%
Over 6 Months
LowHigh
40.178.7
↓-28.7%
Over 1 Year
LowHigh
40.180
Valencia Nutrition Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| ARYAMAN BROKING LIMITED | Bulk | Purchase | 28 Aug 2026 | 50 | 111,000 | BSE |
| KRISHNA N MEHTA HUF | Bulk | Sell | 28 Aug 2026 | 50 | 111,000 | BSE |
| JASH VENTURES | Bulk | Purchase | 15 Feb 2024 | 81 | 90,000 | BSE |
| AMI ASHISH DOSHI | Bulk | Sell | 15 Feb 2024 | 81 | 90,000 | BSE |
| HARSHIL SHAVDIA HUF | Bulk | Purchase | 27 Dec 2023 | 60 | 102,000 | BSE |
| KIRAN AMIT DOSHI | Bulk | Sell | 27 Dec 2023 | 60 | 102,000 | BSE |
| EMRALD COMMERCIAL LIMITED | Bulk | Purchase | 27 Dec 2023 | 60 | 78,000 | BSE |
| VINOD HARILAL JHAVERI | Bulk | Sell | 27 Dec 2023 | 60 | 78,000 | BSE |
| JMR VENTURES | Bulk | Sell | 19 May 2023 | 21 | 39,000 | BSE |
| MUKESH B SHAH HUF | Bulk | Purchase | 19 May 2023 | 21 | 39,000 | BSE |
Valencia Nutrition Corporate Actions
Valencia Nutrition Board Meetings
Valencia Nutrition past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
114 Nov 2026 | Half Yearly Results | - |
228 May 2026 | Audited Results | - |
313 Nov 2025 | Half Yearly Results | - |
428 May 2025 | Audited Results | - |
513 Feb 2025 | Others | Inter-alia, to consider 1. Fund Raising by the issue of permissible securities or through any other permissible mode. 2. Other business matters. |
Valencia Nutrition Rights issue
Valencia Nutrition rights issue history, along with record, ex-rights dates, and rights ratios.
#Ex-Date | Ratio | Face Value | Premium | Record Date |
|---|---|---|---|---|
107 Mar 2024 | 15.0:10.0 | 10 | 16 | 07 Mar 2024 |
Valencia Nutrition Corporate Filings
Valencia Nutrition BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 14 Nov 2026 | Valencia Nutrition Ltd - 542910 - Submission Of Half-Yearly Business Update For FY 2026-27 (As On September 30,2026) | Pursuant to the Board Meeting held that is November 14, 2026, we hereby submit the Half- Yearly Business Update of the Company for Financial Year 2026-27, as on September 30, 2026, for your information and records. | |
| 14 Nov 2026 | Valencia Nutrition Ltd - 542910 - Disclosure Of Related Party Transactions (RPT) Pursuant To Reg. 23(9) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Half-Year Ended September 30, 2026. | In compliance with Regulation 23(9) of SEBI (LODR) Regulation 2015, Valencia Nutrition Limited hereby submits the disclsoure of the Related Party Transactions for the half year ended September 30, 2026. | |
| 14 Nov 2026 | Valencia Nutrition Ltd - 542910 - Disclosure Of Statement Of Deviation Or Variation Pursuant To Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half-Year Ended September 30, 2026 And Disclosure Regarding Forfeiture Of Unexercised Convertible Warrants | In compliance with Regulation 32 of the SEBI (LODR) Regulation 2015, Valencia Nutrition Limited hereby submits Statement of Deviation or Variation for half-year ended September 30, 2026. and also disclose regarding forefeiture of Unexercised warrants. | |
| 14 Nov 2026 | Valencia Nutrition Ltd - 542910 - Outcome Of Board Meeting Held On Saturday, November 14, 2026, At 11:00 A.M. Ref: Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | Pursuant to Regulation 30 and 33 of the SEBI (LODR) Regulations 2015, we wish to inform your good office that the Board of Directors at the Board Meeting Dated 14.11.2026 approved and taken on record Un-audited Financial Results (Standalone and Consolidated) and Limited Review Report. | |
| 14 Nov 2026 | Valencia Nutrition Ltd - 542910 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, November 14, 2026, At 11:00 A.M.
Ref: Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements)
Regulations, 2015 | Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations"), we wish to inform your good office that the Board of Directors of Valencia Nutrition Limited, at its meeting held today, i.e., Saturday, November 14, 2026, which commenced at 11:00 a.m. and concluded at 18:30 p.m., has, inter alia, approved and taken on record Un-audited financial results, Limited Review report. |
Valencia Nutrition Documents
Valencia Nutrition - Company Profile
Valencia Nutrition Management Structure
Valencia Nutrition management structure with salaries, total experience, and qualifications.
Valencia Nutrition Board of Directors
Valencia Nutrition Board of directors with salaries, total experience, and qualifications.
Website: www.valencianutrition.com
About the company - Business Profile
Valencia Nutrition Ltd. (now known as Valencia India Limited) is a specialist nutraceutical company focused on the development and marketing of functional beverages and clinical nutrition products. The company primarily targets the health-conscious consumer segment with products designed to provide specific nutritional benefits. Valencia's role in the industry is that of a developer and brand owner in the fast-moving consumer healthcare (FMCH) space, operating with a lean business model that emphasizes product formulation and brand building.
Key Points
- Key Facts:
- Founded Year: 2017 (as Valencia India Private Limited).
- Headquarters: Ahmedabad, Gujarat.
- Stock Listing: Listed on the Bombay Stock Exchange (BSE) with Scrip Code 544433.
- Legal Status: Converted from a Private Limited to a Public Limited company, now operating as Valencia India Limited.
- Operations and Resources:
- The company operates from its registered office in Ahmedabad and maintains a branch office in Mumbai.
- It utilizes a contract manufacturing model, focusing its internal resources on research, development, and marketing rather than heavy industrial infrastructure.
- Business Model and Expertise:
- Valencia specializes in "Functional Foods and Beverages." It is skilled at identifying nutritional gaps and formulating ready-to-drink products that serve as alternatives to traditional supplements.
- The company focuses on clinical nutrition and preventive healthcare, positioning itself as a science-backed consumer brand.
- Financial Performance (Annual 2024-25):
- Revenue from Operations: ₹757.73 Lakhs for the full year ended March 31, 2025.
- Net Profit: The company reported a net profit of ₹211.30 Lakhs for FY 2024-25.
- Recent Half-Year (H1 FY26): For the period ended September 30, 2025, the company recorded revenue of ₹387.98 Lakhs and a net profit of ₹96.77 Lakhs.
- Key Products and Technology:
- The core product portfolio includes functional drinks under brands such as "VitaMe" (nutrient-infused water) and "Bounce".
- Technology focus: Development of nutrient-stable formulations that ensure vitamin and mineral integrity in liquid form without the use of excessive preservatives.
- Capital Structure:
- As of September 30, 2025, the paid-up equity share capital stood at ₹1,299.96 Lakhs.
- The company successfully raised capital through an Initial Public Offering (IPO) recently, which is reflected in the significant increase in reserves and surplus to ₹4,328.48 Lakhs by September 2025.
- Strategic Initiatives:
- The company is actively expanding its distribution footprint beyond its primary markets in Gujarat and Maharashtra.
- Current focus remains on scaling its functional beverage portfolio and exploring new categories in the clinical nutrition segment to drive higher margins.
References
